ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	16 December 2017
Main ID:	NCT00846560
Date of registration:	15/02/2009
Prospective Registration:	No
Primary sponsor:	Rambam Health Care Campus
Public title:	Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)
Scientific title:	Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)
Date of first enrolment:	August 2008
Target sample size:	0
Recruitment status:	Withdrawn
URL:	https://clinicaltrials.gov/show/NCT00846560
Study type:	Observational
Study design:
Phase:	N/A

Countries of recruitment
Israel

Contacts

Key inclusion & exclusion criteria

Inclusion Criteria:

- ALS patients who could sign ICF.

Exclusion Criteria:

- No ALS patients age less than 18 years.

Age minimum: 18 Years
Age maximum: 100 Years
Gender: All

Health Condition(s) or Problem(s) studied

Amyotrophic Lateral Sclerosis

Intervention(s)

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

ALS04CTIL

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.